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an effective vaccine antigen to protect against
cattle tick infestations
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Background: Vaccination as a control method against the cattle tick, Rhipicephalus (Boophilus) microplus has been
practiced since the introduction of two products in the mid-1990s. There is a need for a vaccine that could provide
effective control of R. microplus in a more consistent fashion than existing products. During our transcriptome
studies of R. microplus, several gene coding regions were discovered to encode proteins with significant amino
acid similarity to aquaporins.
Methods: A cDNA encoding an aquaporin from the cattle tick, Rhipicephalus microplus, was isolated from
transcriptomic studies conducted on gut tissues dissected from fully engorged adult female R. microplus.
Results: Bioinformatic analysis indicates this aquaporin, designated RmAQP1, shows greatest amino acid similarity to
the human aquaporin 7 family. Members of this family of water-conducting channels can also facilitate the transport of
glycerol in addition to water. The efficacy of this aquaporin as an antigen against the cattle tick was explored in cattle
vaccine trials conducted in Brazil. A cDNA encoding a significant portion of RmAQP1 was expressed as a recombinant
protein in Pichia pastoris, purified under native conditions using a polyhistidine C-terminus tag and nickel affinity
chromatography, emulsified with Montanide adjuvant, and cattle vaccinated intramuscularly. The recombinant
protein provided 75% and 68% efficacy in two cattle pen trials conducted in Campo Grande, Brazil on groups of
6 one year old Holstein calves.
Conclusion: The effectiveness of this vaccine in reducing the numbers of adult female ticks shows this aquaporin
antigen holds promise as an active ingredient in cattle vaccines targeted against infestations of R. microplus.
Keywords: Cattle tick, Recombinant protein, Vaccine antigen, AquaporinBackground
The cattle tick, Rhipicephalus (Boophilus) microplus, is
an obligate parasitic cattle pest that has established pop-
ulations throughout the world’s tropical and subtropical
regions. R. microplus is responsible for significant eco-
nomic losses to cattle producers because of direct effects
through blood loss and damage to hides and indirect ef-
fects through diseases it transmits such as babesiosis and
anaplasmosis. For example, Grisi et al. [1] estimated Brazil’s
annual losses to R. microplus parasitism approximate US* Correspondence: Felix.Guerrero@ars.usda.gov
1USDA-ARS Knipling Bushland US Livestock Insect Research Laboratory,
2700 Fredericksburg Rd., Kerrville, TX 78028, USA
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Dedication waiver (http://creativecommons.or
unless otherwise stated.$3.2 billion. Significant efforts to control this tick are
undertaken in most cattle-raising countries and these
efforts presently center around the use of acaricides.
However, acaricide resistant populations of R. microplus
have become a major problem in most of the cattle-
producing countries of the world and novel cattle tick
control technologies are needed to maintain efficiencies in
cattle production [2-4].
Vaccination as a tick control method has been practiced
since the introduction of two products in the mid-1990s,
TickGARD [5] and Gavac© [6], that were developed using
the midgut glycoprotein Bm86 as the immunoreactive
antigen. TickGARD is no longer commercially available,
but Gavac© continues to be used to date, primarily inal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Gavac© have been mixed, within integrated tick manage-
ment systems in some geographic regions, the vaccine has
proven to reduce the number of acaricidal applications
per year that are required to control R. microplus at ac-
ceptable levels [7]. As an interesting sidelight to the role
of Gavac© in cattle tick control, the product has been
shown to provide >99% efficacy against Rhipicephalus
annulatus, a second cattle tick species which is much less
prevalent and invasive than R. microplus [8,9]. Neverthe-
less, the need remains for a vaccine that could provide
effective control of R. microplus in a more consistent
fashion than Gavac©. As part of research mining the
genome of R. microplus for transcripts that would pro-
duce effective antigens for a cattle tick vaccine, focused
genome [10], transcriptome [11], and proteome [12,13]
studies in R. microplus have led to identification of
genes and gene coding regions that encode proteins
with critical functions in the tick [14,15]).
Several of these gene coding regions were discovered to
encode proteins with significant amino acid similarity to
aquaporins. Aquaporins, originally called water channels,
allow the regulation of water transport across the highly
hydrophobic lipid bilayer of cell membranes. Members of
the aquaporin family have been found in animal taxa from
mammals [16] to bacteria [17] and they are very common
in certain cell types, with approximately 150,000 protein
copies per red blood cell [18]. The structure of the aqua-
porins is such that two constrictions in the protein act as
filters whose selectivity for water, glycerol, urea, and other
small molecules is determined by the size and charge of
the constriction pore [19]. Because cattle ticks ingest large
volumes of blood relative to their body size and weight,
they are required to have efficient water transport mecha-
nisms so as to concentrate the blood components for effi-
cient digestion [20]. Thus, the tick aquaporins are critical
to tick physiology and appeared a good protein to target
as an anti-cattle tick vaccine candidate. The full length
transcript for one of the discovered aquaporins, desig-
nated RmAQP1, was determined and a fragment of the
open reading frame (ORF) was expressed and purified as a
recombinant protein in Pichia pastoris. This recombinant
protein was tested in cattle pen trials for efficacy as a vac-
cine antigen against R. microplus.
Methods
Source of tick materials
Ticks that were the source of DNA and RNA for the
transcript discovery study were obtained from engorged
adult female R. microplus of the f20 La Minita strain
maintained at The University of Idaho Holm Research
Center (Moscow, ID). The La Minita strain was originally
collected in 1996 during an outbreak in Starr County, TX
and propagated at the USDA-ARS Cattle Fever TickResearch Laboratory in Edinburg, TX. Tissues that were
the source of RNA for gene expression study were dis-
sected from 25 1–2 day old adult male and female ticks
from the R. microplus Deutch strain f41 generation main-
tained at the Cattle Fever Tick Research Laboratory. The
Deutch strain is an organophosphate and pyrethroid sus-
ceptible strain originating from an outbreak in 2001 in
Webb County, Texas. Tick larvae used in this study to in-
fest cattle for the cattle vaccine trials were obtained from
a laboratory colony maintained at EMBRAPA Beef Cattle.
The colony was established with R. microplus ticks col-
lected from infested cattle in Campo Grande, MS, Brazil.
Larvae used for infesting cattle in the vaccine trials were
18 days post-hatch. During the vaccine trials, fully
engorged adult female ticks were collected upon host de-
tachment and brought to the laboratory to allow ovipos-
ition. Egg masses were incubated in humidity chambers at
28°C and 95% relative humidity to facilitate hatching. Lar-
vae were used for infestation at 18 days after hatching.
RNA purification, cDNA synthesis & RACE
Total RNA was isolated using the FastPrep-24 Tissue and
Cell Homogenizer and Lysing Matrix D (Qbiogene, Irvine,
CA, USA) as described in Saldivar et al. [21] from gut tis-
sue dissected from 5 engorged adult female R. microplus
from the La Minita strain. The total RNA was DNAse
treated following manufacturer’s protocol using Turbo
DNA-free kit (Ambion, Austin, TX, USA).
One microgram DNase-free total RNA was used to
make 5′ and 3′ cDNA using the SMART RACE cDNA
Amplification Kit (Clontech Laboratories Inc., Mountain
View, CA, USA) and Superscript III Reverse Transcript-
ase (Life Technologies, Grand Island, NY, USA). Primers
(Sigma-Aldrich, The Woodlands, TX, USA) were designed
from the available aquaporin-like sequence obtained from
GenBank Accession No. CV443183 [11], synthesized, and
used to obtain the full length coding region sequence. The
target 5′ end was obtained using 20 μL PCR reactions
containing 5′ SMART RACE cDNA, Advantage® 2 PCR
Enzyme System (Clontech Laboratories Inc.), Universal
Primer A and gene specific primer KB-126 (Table 1)
according to manufacture’s protocol using the touch-
down cycling profile suggested in the SMART RACE
protocol booklet. This amplification product was used
for a nested PCR using Nested Universal Primer A and
gene specific primer KB-126 following manufacturer’s
protocol using a cycling profile of thirty cycles includ-
ing a denaturing step of 94°C for 30 sec and an annealing/
extension step of 72°C for 3 min 30 sec. PCR products
were analyzed by electrophoresis on 2% SeaKem Gold
agarose gels in 1XTBE running buffer (Lonza Rockland,
Inc., Rockland, ME, USA) and post-stained using GelStar®
Nucleic Acid Gel Stain (Lonza Rockland, Inc.). The de-
tected 965 bp amplicon was excised from the agarose gel
Table 1 Primers/Probes used for RmAQP1 transcript cloning and real-time PCR
Primer ID Sequence Use
KB-126 5′ GAGCGGGCACATGCAGTTGTAGGC 3′ Reverse for Aquaporin 5′ RACE
KB-156 5′ ACTCAGGAATTCATGAAGATCGAGAACCT 3′ Forward for insertion into pPICZ αA EcoRI
KB-157 5′ TCACTGGCGGCCGCCGGGCACATGCAGTTGTAGGC 3′ Reverse for insertion into pPICZ αA NotI
KB-238 5′ TCGCCAAAGTGCCGCTATAC 3′ Aquaporin RT-PCR Forward
KB-239 5′ CGTCTTTGTAGGTGGCAAACAC 3′ Aquaporin RT-PCR Reverse
KB-240 5′ 6FAM-CGCCGCACCGACGAAGCCAC-TAMRA 3′ Aquaporin TaqMan Probe
KB-263 5′ TAAGGACCTGTACGCCAACAC 3′ Beta-actin RT-PCR Forward
KB-264 5′ CGGTGATTTCCTTCTGCATACG 3′ Beta-actin RT-PCR Reverse
KB-265 5′ 6FAM-TCTCCGGCGGCACCACCATGTACC-TAMRA 3′ Beta-actin TaqMan Probe
AF018656-363 F 5′ CCTGAGAAACGGCTACCACATC 3′ 18S rRNA RT-PCR Forward
AF018656-425R 5′ GTGCCGGGAGTGGGTAATT 3′ 18S rRNA RT-PCR Reverse
AF018656-387 5′ 6FAM-AGGAAGGCAGCAGGCGCGC-TAMRA 3′ 18S rRNA TaqMan Probe
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Extraction Kit (Qiagen, Valencia, CA, USA) according
to manufacturer’s protocol. The DNA was concentrated
using Pellet Paint Co-Precipitant (Novagen/EMD Chemicals
Inc., Gibbstown, NJ, USA), polished, ligated and trans-
formed into XL10 Gold Kan Ultracompetent Escherichia
coli cells using the PCR Script Amp Cloning Kit
(Stratagene/Agilent Technologies Inc., Santa Clara, CA,
USA). Individual clones were screened via PCR using in-
ternal vector primers and clones producing a correct
sized product were used for plasmid DNA preparations
with the QIAprep Spin Miniprep Kit (Qiagen) according to
manufacturer’s instructions. Plasmid DNAs were sequenced
on a 3130xl Genetic Analyzer (Applied Biosystems, Foster
City, CA, USA). Identities of each nucleotide in RmAQP1
were verified on both strands to produce a high quality
sequence. Sequences were assembled and analyzed using
MacVector with Assembler version 10.0.2 (MacVector
Inc., Cary, NC, USA). Basic Local Alignment Search
Tools (BLAST) programs were run using multiple BLAST
programs available at http://blast.ncbi.nlm.nih.gov/Blast.
cgi [22,23]. TOPCONS ([24], http://topcons.net/index.
php) was used for the prediction of transmembrane
helices in proteins. Net Phos 2.0 Server ([25], http://www.
cbs.dtu.dk/services/NetPhos) was used for the predictions
of serine, threonine, and tyrosine phosphorylation sites.
Real-time PCR gene expression study
Quantitative PCR studies were designed with the MIQE
guidelines in mind [26]. Tissue dissections were per-
formed under phosphate-buffered saline pH =7.4. The
tissues dissected from the female ticks were the syngan-
glia, salivary glands, ovaries and midgut while tissues
dissected from the male ticks were the synganglia, saliv-
ary glands, testes, accessory gland and midgut. Dissected
tissues were placed in RNALater (Ambion, Austin, TX,
USA) according to manufacturer’s protocol. Total RNAwas isolated using the ToTALLY RNA Kit (Ambion) and
DNase treated using the Turbo-DNA free kit (Ambion)
according to manufacturer’s protocol. The RETROscript
Kit Reverse Transcription for RT-PCR (Ambion) was
used to produce cDNA from each tissue using 0.1 μg
of DNase-free total RNA.
TaqMan probes and primers were designed using
Beacon Designer 7.0 (PREMIER BioSoft International,
Palo Alto CA; Table 1) and synthesized by Sigma-Aldrich
Inc. (The Woodlands, TX, USA) for RmAQP1 and the
two reference genes used for normalization, R. microplus
18S rRNA gene [21] and beta-actin. Optimization PCRs
were run on all three genes to determine optimal reaction
conditions, PCR efficiencies, and optimal reagent concen-
trations. Real-time PCR reactions were carried out in clear
low profile 96 well plates (BioRad, Hercules, CA, USA)
with microseal film B (BioRad) using 25 μL total volume
reactions, which included TaqMan Universal Master Mix
No AmpErase UNG (Applied Biosystems Inc.), 250 nM
TaqMan probe, tissue specific RETROscript cDNA, and
900 nM forward and reverse primers for all three genes.
The cycling profile used on the BioRad CFX96 Real-Time
System was 95°C for 10 min, and 50 cycles of 95°C for
15 sec, 60°C for 1 min plus plate read. All samples were
run in triplicate and both no-template and no-reverse
transcriptase controls were utilized to verify DNA-free
status of the samples. The fluorescence emission data ana-
lysis for the relative standard curve method for quantifica-
tion was done using baseline subtracted curve fit mode
with CFX Manager Software v1.5 (BioRad).
Cloning into Pichia pastoris
The partial RmAQP1 ORF used for the vaccine study
was amplified with the Advantage® 2 PCR Enzyme Sys-
tem (Clontech Laboratories Inc.) using primers KB-156
and KB-157 (Table 1). The 597 bp amplification product
was purified and gel extracted as described above. The
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enzyme digestion reactions with EcoRI and NotI (Life
Technologies) per manufacturer’s protocol.
The EasySelect Pichia Expression Vector (Life Technolo-
gies), pPICZ αA restriction enzyme-digested with EcoRI
and NotI and purified, was ligated onto the RmAQP1
DNA using the TA Cloning Kit (Life Technologies) using
the TA Cloning Kit protocol and 137 ng RmAQP1 insert,
50 ng pPICZ αA EcoRI/NotI digested vector, and 1 unit T4
DNA ligase incubated for 17 hr at 4°C. OneShot TOP10
Electrocomp cells (Life Technologies) were transformed
with ligation reaction and plated on low salt LB agar (1%
tryptone, 0.5% yeast extract, 0.5% sodium chloride, 1.5%
agar) with 25 μg/mL ZeocinTM (Life Technologies). Result-
ing colonies were screened via PCR using vector primers
5′AOX1 and 3′ AOX1 and DNA isolated from positive
colonies using the QIAprep Spin Miniprep Kit (Qiagen)
according to manufacturer’s instructions. The sequence of
both strands of putative positive clone plasmid DNA was
verified by DNA sequencing, followed by analysis with
MacVector with Assembler version 10.0.2.
According to the EasySelect Pichia Expression Kit
protocol, a freshly prepared 80 μL aliquot of electrocom-
petent P. pastoris KM71H strain and 5 μg recombinant
expression vector DNA linearized with SstI was used for
transformations according to the manufacturer’s instruc-
tions using the Bio-Rad Gene Pulser and Pulse Controller
at pulse settings of 1.5 kV, 200Ω and 25μFD. Transform-
ation mixtures were plated on YPDS (1% yeast extract, 2%
peptone, 2% dextrose, 1 M sorbitol, 2% agar) plates con-
taining 100 μg/mL ZeocinTM and incubated at 30°C for
four days to allow colonies to develop.
Analysis of Pichia pastoris transformants
Direct screening of individual Pichia KM71H colonies
using PCR was done by modifying the direct screening
protocol from Linder et al. [27] and the EasySelect
Pichia Expression Kit manual with 25 μL reactions using
the 5′ and 3′ AOX1 vector primers and 0.16 μL of a 1
vol:1 vol mix of AmpliTaq DNA polymerase (5 U/μL stock;
Applied Biosystems) and TaqStart antibody (1.1 μg /μl
stock; Clontech). Colonies containing the expected
1,192 bp recombinant product were re-screened using
a similar approach but substituting RmAQP1-specific
primers.
Selected colonies were Mut phenotyped and small-scale
expression experiments used to determine the optimal
method and conditions for the expression of the recom-
binant proteins. These protocols are described in the
EasySelect Pichia Expression Kit manual for 3 mL cul-
tures grown in BMGY (1% yeast extract, 2% peptone,
100 mM potassium phosphate pH =6.0, 1.34% Yeast
nitrogen base with ammonium sulfate without amino
acids, 4 × 10−5% biotin, 1% glycerol) and BMMYmedia (BMGY but substituting 0.5% methanol for the
1% glycerol). BMMY cultures were replenished to
0.5% final methanol concentration every 24 hr. Samples
were collected at various time points and centrifuged to
separate the yeast cells from the culture media supernatant.
Supernatants were frozen in liquid nitrogen and stored
at −80°C. Intracellular proteins were purified by a proto-
col similar to that described in the EasySelect Pichia
Expression Kit manual. Briefly, 100 μl of breaking buffer
(50 mM sodium phosphate pH7.4, 1 mM EDTA, 5%
glycerol) +1X FOCUS ProteaseArrest (GBioscience,
St. Louis, MO) was used per cell pellet from a 1 ml
culture sample. An equal volume of 0.5 mm acid-washed
glass beads was added and the sample vortexed for 30 sec
and set on ice for 30 sec. A total of 8 vortex/ice cycles
were used, the sample frozen at −80°C, thawed and 8
more vortex/ice cycles used before a final short centrifuga-
tion to clarify the sample. Samples were concentrated in
Amicon Ultracel units (Millipore, Billerica, MA) when
necessary.
Both the intracellular cell pellets and the secreted super-
natant samples were analyzed by denaturing gel electro-
phoresis under reducing conditions using the NuPAGE®
Electrophoresis System and NuPAGE® 4-12% Bis-Tris gels
in the XCell SureLockTM Mini-Cell with 1X NuPAGE
MOPS SDS Running Buffer (Life Technologies) according
to manufacturer’s instructions. Proteins were visualized
by staining with Coomassie Brilliant Blue R-250 using
a modified Fairbank’s method [28]. Recombinant aqua-
porin was localized in the cell pellet sample with max-
imal expression seen after 4 days of induction growth
in BMMY.
After the optimal clone and growth conditions were
determined, a large scale culture of the clone producing
the highest amount of recombinant aquaporin protein
was grown in 25 mL BMGY media in 500 ml baffled
flasks in a shaking incubator at 30°C to an OD600 = 2-6.
Cells were harvested by centrifugation and resuspended
in BMMY to an OD600 = 1 and returned to the incubator
for 4 days to induce expression. Every 24 hr, methanol
was added to a final concentration of 0.5% to maintain in-
duction and cells were harvested 4 days post-induction.
Following centrifugation, the cell pellet was frozen at −70°C
until protein extraction.
Total yeast intracellular protein was extracted similarly
as described above for the small-scale expression cell
pellet protocol with the exception of using 50 mL Break-
ing Buffer with 1X Protease Arrest and 10 cycles of
30 sec vortexing followed by 30 sec on ice. The cell pel-
let lysates were then frozen at −70°C overnight and
thawed followed by 10 vortex/ice cycles. The protein so-
lution was clarified by centrifugation and the resulting
solution concentrated using Centricon Plus-70 Centrifugal
Filter Devices (Millipore).
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Recombinant protein was purified making use of the
6X-Histidine tag supplied by the vector sequence and
the ProBond Purification System (Life Technologies)
using ProBondTM nickel-chelating resin under native
conditions, initially according to manufacturer’s instructions.
We wished to preserve the native protein structure, thus we
did not use urea, SDS, or heat in the purification steps.
However, the purified protein presented solubility problems
upon freezing and thawing and we adapted the ProBond
purification steps to utilize buffer (50 mM NaH2PO4 pH=
8.0, 300 mM NaCl, 2 mM β-mercaptoethanol, 0.4% β -D-1-
thioglucopyranoside) plus 10 mM imidazole for binding, the
same buffer plus 30 mM imidazole for washing, and buffer
plus 300 mM imidazole for elution [29]. Eluted protein was
concentrated using Amicon Ultra-15 centrifugation units
(Millipore) and, following concentration, the solution was
made 50% v/v glycerol and stored at −20°C. This protein
solution was used to prepare the vaccine. Protein con-
centration was quantified by the BioRad Protein Assay
Kit I with bovine plasma gamma globulin protein stan-
dards, and purity of the protein solution verified by gel
electrophoresis as described above using the NuPAGE®
Electrophoresis System and NuPAGE® 4-12% Bis-Tris
gels in the XCell SureLockTM Mini-Cell.
Protein identity was verified by mass spectrometry ana-
lysis and Western blotting, taking advantage of the c-myc
and 6X-His tag epitopes on the recombinant protein thatFigure 1 Nucleotide and translated open reading frame (ORF) sequen
of the transcript as determined by RACE. Amino acid numbering begins from th
portion of the ORF used as the vaccine antigen is underlined. The six predicted
and 231–251) and the two NPA motifs (aa # 68–70 and 201–203) are highlighte
280, 287, 295, and 297), 3 threonine (aa # 107, 123, and 223), and 1 tyrosine (aa
stop codons are present both upstream of the presumptive methionine start anare provided by the expression vector sequence. The
WesternBreeze Chromogenic Kit and Anti-myc-HRP
and Anti-His(C-term)-HRP antibodies (Life Technologies)
were utilized with standard protocols provided by the sup-
plier. The supplier-provided alkaline phosphatase-conjugated
secondary antibody was utilized to enhance sensitivity. The
mass spectrometry analysis was done by Protea Bioscience
Group (Morgantown, WV). The recombinant protein
(in 50% glycerol solution described above) was purified
by 1-D acrylamide gel electrophoresis, extracted from the
gel matrix, and digested with trypsin. The resulting pep-
tides were analyzed by LC-MS/MS using an ABSciex5500
Series QTRAP for tandem MS data acquisition followed
by a search for peptide matches to the expected sequence
of purified antigen.
Pen trial
Controlled pen trials were conducted to evaluate the im-
munogenic and protective capacity of the aquaporin
antigen adjuvated with Montanide ISA 61 VG (Seppic,
Paris) into doses of 2 ml containing 100 μg of the re-
combinant protein and phosphate-buffered saline (PBS).
One-year-old Holstein calves were randomly distributed
into groups of six animals each. Negative controls were
injected with adjuvant prepared with PBS alone. The an-
imals were injected intramuscularly three times with two
week intervals between injections. Serum samples were
taken from each animal before the first immunizationces for RmAQP1. Nucleotide sequence numbering starts from the 5′ end
e start methionine amino acid. The entire ORF is in bold text, while the
transmembrane helices (aa # 11–31, 43–63, 88–108, 144–164, 176–196,
d. The predicted phosphorylation sites at 8 serine (aa # 64, 77, 207, 265,
# 229) amino acid residues are indicated in outline font. Multiple in-frame
d downstream of the stop TAG codon.
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jection the animals were challenged with 15,000 larvae
of the Campo Grande tick strain. These larvae were de-
livered in three applications of 5,000 larvae each during
one week, placed in separate vials onto the back of the
animals. As engorged female ticks detached, they were
collected once a day, pooled, and weighed. This sam-
pling was initiated upon the first day detachment
started and continued until tick detachment ceased,
which was 19 days for Trial 1 and 16 days for Trial 2.
Twenty females from each day’s collection were pooled
and incubated at 29°C and 85% humidity until egg laying
was complete. Eggs collected from each pool wereFigure 2 Amino acid sequence alignments of RmAQP1-3 with putativ
ClustalW multiple alignment function of MacVector 12.7.5 using the Gonne
Determination of amino acid similarity was by chemical properties of amino
groups considered as conservative substitutions. The accession numbers for the p
I. ricinus, and D. variabilis are CD780384, CAR66115, XP_002399794, CAX489
aquaporin families 3 (NP 004916) and 7 (NP 001161) are also included in the a
sequences, with identities indicated by colon (:) and similarities by period (.). I
amino acid positions where all 10 sequences contain the identical amin
similar amino acids, and an asterisk (*) indicates 9 of the 10 aligned sequ
optimize alignments are indicated by a dash (−). The shaded portions o
helical regions.weighed and incubated at 29°C and 85% humidity until
hatching was completed to determine the hatch per-
centage for each pool.
Bovine serum collection and analysis
Bovine blood was sampled weekly and separated serum
frozen until analyzed by ELISA. For the ELISA, sera
from all animals in each group were pooled according to
day of collection. Microtiter plates were coated with anti-
gen (50 μL per well of a 1 μg antigen/ml solution in
20 mM sodium carbonate buffer, pH 9.6) and incubated
overnight at 4°C. Blocking with 2% bovine serum albumin
in PBS pH 7.4 containing 0.05% Tween 20 was followede aquaporins from other tick species. Alignment was by the
t matrix with open gap penalty of 10 and extend gap penalty of 0.05.
acid side chains with DE, AGILV, NQ, FWY, RHK, ST, CM, and P comprising the
utative tick aquaporins from R. appendiculatus, R. sanguineus, I. scapularis,
64, and ABI53034, respectively. One member each from the human
lignment. The RmAQP1 was used as the model for comparing other
n the summary line below the 10 aligned sequences, a colon (:) notes
o acid, a period (.) indicates all 10 sequences contain identical or
ences have identical or similar amino acids. Gaps inserted to
f the RmAQP1 sequence indicate the six predicted transmembrane
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incubated for 45 min at 37°C with 100 μL per well of im-
munized bovine serum diluted to 1:100 in PBS. After
washing in PBS pH 7.4, 50 μl of rabbit anti-bovine IgG
peroxidase conjugate (Sigma, St. Louis, MO, USA) diluted
1:20,000 was added and the plate incubated for 30 min at
room temperature. After washing in PBS pH 7.4, 50 μl
of 1.0 mM chromogenic substrate o-phenylenediamine
was added and the reaction was stopped after 15 min
by adding 50 μl of 0.2 M NaOH. A microplate reader was
used to assess the results with absorbance set at 490 nm.Efficacy assessment and statistics
Reductions associated with immunization relative to the
unvaccinated group were determined for numbers of
adult female ticks, egg production, and larval hatching.
Vaccine efficacy was calculated as 100 × [1 – (NET ×
EWPF × H)], where NET, EWPF, and H represent the
fraction of the relevant tally in the immunized group
relative to that in the control group of the total number
of adult female ticks, total weight of eggs per female,
and % hatch of eggs, respectively.Ethical approval
The La Minita ticks used for the transcript discovery
study were reared at The University of Idaho Holm Re-
search Center (Moscow, ID, USA) following protocols
approved by the University of Idaho Institutional Animal
Care and Use Committee (IACUC). The Deutch ticks
used for the gene expression studies were reared at the
USDA- ARS Cattle Fever Tick Research Laboratory
(Edinburg, TX, USA) with protocols approved by that
Laboratory’s IACUC. The cattle vaccine studies were
conducted at EMBRAPA Beef Cattle (Campo Grande,
MS, Brazil) under protocols approved by the EMBRAPA
review board.Figure 3 Phylogenetic tree of putative tick aquaporins. A phylogenetic
using the MacVector 12.7.5 package. The analysis was performed using the
bootstrap mode with 1000 replicates. Tie breaking was set as systematic anResults
Aquaporin-like sequences from the cattle tick
Using ESTs from BmiGI Ver 2.0 as a starting point [11],
we used 5′ RACE to isolate an 1,800 bp transcript that
included the entire ORF to an aquaporin-like protein
(Figure 1; GenBank Accession No. KJ626366). As this is
the first aquaporin from R. microplus to be described,
we designated the transcript as RmAQP1. The transcript
encodes a 216 aa ORF with several stop codons flanking
both the N- and C-termini of the presumptive protein,
increasing our confidence that we have the authentic
ORF. Analysis by TOPCONS (http://topcons.net/index.
php) predicted the ORF contains 6 transmembrane hel-
ical regions and two NPA motifs, all characteristics of
the aquaporin family [30]. The Net Phos 2.0 Server
(http://www.cbs.dtu.dk/services/NetPhos) predicted 8 serine,
3 threonine, and 1 tyrosine phosphorylation sites.
We searched other cattle tick transcriptome datasets
from ongoing studies in our group and we found 2 other
ESTs encoding putative full-length aquaporin-like ORFs,
designated RmAQP2 and RmAQP3, and 9 ESTs encod-
ing partial aquaporin-like ORFs (Additional file 1). We
produced a ClustalW multiple alignment of RmAQP1-3
with other aquaporin-like ORFs from 5 tick species
(Figure 2). The regions that align with the RmAQP1
transmembrane helices 2–6 display more amino acid
similarity than other aligned regions. However, the re-
gion between predicted transmembrane helices 5 and 6
has a high number of identities in the alignment (Figure 2).
In fact, that region between helices 5 and 6 contains 12 of
the 40 invariant amino acids that exist over the entire
alignment. The phylogenetic tree (Figure 3) that was pro-
duced from this alignment showed that RmAQP1 is most
similar to the aquaporin from Ixodes scapularis (GenBank
Accession No. XP_002399794). RmAQP2 was most similar
to the aquaporin from Dermacentor variabilis (GenBank
Accession No. ABI53034), while RmAQP3 was mosttree of the multiple sequence alignment of Figure 2 was determined
neighbor joining method using uncorrected distance option and
d gaps distributed proportionally.
Table 2 Gene expression of RmAQP1 in various tissues of
R. microplus
Tissue Relative expression level




Salivary gland 4.2 21
Testes 25 14




Salivary gland 3.0 4.2
Ovary 2.2 0.7
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tus (GenBank Accession No. CD780384) and Rhipicepha-
lus sanguineus (GenBank Accession No. CAR66115). In
the tissue-specific gene expression study, RmAQP1 was
expressed most highly in the synganglia and lowest in the
gut of male ticks, while females expressed RmAQP1
most highly in the synganglia and lowest in the ovary
(Table 2).Figure 4 Gel electrophoresis of recombinant antigen expressed in P.
Ten μg of purified protein was added to an equal volume of sample buffer
blue, 5% β-mercaptoethanol), heated for 5 minutes at 90°C, and electropho
G-250 the gel was destained with water for approximately 3 d before the in
Lane 1: protein molecular weight standards; Lane 2: empty; Lanes 3 and 4: 10 μ
33.9 kDa (sequence in Additional file 1: Table S1) expressed in P. pastoris; Lanes
B) Ten μg of purified protein was electrophoresed on a NuPAGE® 4-12% Bis-Tris
with the WesternBreeze Chromogenic Kit and Anti-myc-HRP antibody (Invitroge
Purified recombinant Aquaporin-derived vaccine antigen. The blot imag
the visualize the minor background products of approximately 60–65 kDProduction of recombinant aquaporin as vaccine antigen
During the process of determining the sequence of
RmAQP1, an opportunity became available for evaluat-
ing a vaccine antigen in a controlled cattle pen test. At
that time, we had cloned and sequenced only about
600 bp of the transcript, encoding only 91% of what we
eventually determined to be the entire ORF (Figure 1).
Nevertheless, due to the time-limited nature of the cattle
pen test opportunity, we could not complete the tran-
script cloning within the time constraints and chose to
evaluate the existing aquaporin-like antigen as a recom-
binant protein expressed in P. pastoris. The amino acids
that comprised the vaccine antigen are shown underlined
in Figure 1. The sequence encoding those amino acids
was cloned into the P. pastoris expression vector pPICZ
αA and the resulting recombinant protein purified as de-
scribed. The full amino acid sequence of the recombinant
protein is shown in Additional file 1: Table S1 and has a
calculated molecular weight of 33.9 kDa. The first 91
amino acids in the 317 amino acid antigen were from
the pPICZ vector, as were the final 27 amino acids.
The mass spectrometry analysis verified we had pro-
duced the intended protein (Figure 4A). We detected
high confidence peptides FSNSTNNGLLFINTTIASIAAK
and AQASVRKFPIAK from the vector-provided N-terminus
and the RmAQP1-provided ORF, respectively. The Western
blot analysis of the purified protein with anti-myc-HRPpastoris and analyzed by mass spectrometry and Western blot. A)
(4% sodium dodecyl sulfate, 120 mM Tris pH 6.8, 0.02% bromophenol
resed on a 10% polyacrylamide gel. Following staining with Coomassie
dicated band (arrow) was extracted and analyzed by mass spectrometry.
g of purified vaccine antigen protein with calculated molecular weight of
5 and 6: 10 μg of bovine serum albumin protein standard (MW =66.4 kDa);
gel and analyzed by Western blotting using standard protocols provided
n). Lane 1: All Blue Precision Plus Protein Standards (Bio-Rad); Lane 2:
e was adjusted through contrast and brightness controls to enable
a.
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antibodies confirmed the presence of these moieties on
the C-terminus of the antigen.
Cattle pen tests for aquaporin antigen efficacy against
R. microplus
The recombinant aquaporin-derived antigen was tested
with Montanide adjuvant in cattle pen tests. Cattle were
vaccinated at the beginning of the test and two and four
weeks after the start date. Three weeks after the final
immunization, the cattle were challenged with R. microplus
larvae. The results of the cattle tests are summarized in
Figure 5 and detailed in Additional file 2: Table S2, while the
efficacy calculation is shown in Table 3. Trial 1 was con-
ducted from September - December 2010 and Trial 2 was
conducted from March - July 2011. Bovine blood was sam-
pled weekly from each animal and ELISA results showed
that vaccination elicited a specific humoral immune response
(Figure 6; Additional file 3: Table S3). The major effect of the
aquaporin antigen was on the total tick count resulting from
the infestation (Table 3, NET, P <0.001). The two trial groups
vaccinated with the aquaporin-derived antigen produced
29% of the adult female ticks compared to the control (vacci-
nated with PBS+ adjuvant only). The effects on egg produc-
tion and egg hatch were minor (P >0.05), however the extent
of the effect on female tick production resulted in an overall
efficacy of 75% and 68% for the two trials (Table 3).
Discussion
The efficacy of the aquaporin-derived antigen vaccine
against R. microplus in our tests was substantial enoughFigure 5 Tick collection data from cattle stall test vaccine evaluation
reported for A) Average number of ticks collected per animal, B) Average w
female, and D) Average % egg hatch.to warrant further investigation as a potential control
technology against this parasite. Prior to the two pen tri-
als described here, we had conducted a cattle pen trial
using a DNA vaccine approach and an expression vector
encoding the aquaporin-derived antigen described herein
[31]. We obtained approximately 50% efficacy against
R. microplus (data not shown) while a rBmiTI antigen
had approximately 30% efficacy as reported by Andreotti
et al. [32]. Additionally, during the vaccination trials re-
ported here, we also had other antigens being evaluated
for efficacy against R. microplus. For example, in Trial 1 a
salivary gland antigen and in Trial 2 a Bm86-Campo
Grande antigen was evaluated as a separate group in the
pen tests and showed 28% and 49% efficacy, respectively
(data not shown). Thus, the aquaporin-derived vaccine
was shown to outperform the other vaccines in both our
pen trials. The vaccine’s major impact on R. microplus was
to drastically reduce the yield of adult ticks (Table 3). Ef-
fects on average detached female tick weight, average egg
mass weight, and hatch were absent or minor (Additional
file 2: Table S2).
An aquaporin from I. ricinus, IrAQP1 (EMBL Accession
Number FN178519), was evaluated for efficacy using
in vivo feeding assays following dsRNA interference [33].
In contrast to our results, the effects from the IrAQP1
tests were manifested in significant weight reduction in
treated ticks, due to reduced blood ingestion. However, re-
ductions in adult tick mortality were not seen. There are a
number of reasons that might explain the differences be-
tween these aquaporin efficacy tests. There are extensive
differences between these two tick species. For example,trials. For both Trial 1 and Trial 2, means and standard errors are
eight of ticks collected per animal, C) Average egg mass weight per
Table 3 Data from cattle stall trials evaluating RmAQP1-derived protein for efficacy as anti-R. microplus vaccine
antigen
Group Animals Overall tick yield Tests with eggs Hatch NETa EWPFb Hc Effd
No. Total no. Total Wt (g) Tick no. Tick Wt (g) Egg Wt (g) %
Trial 1
Control 6 5901 1701.62 334 91.604 46.286 91.4 - - - -
Aquaporin 5 1482 391.625 300 80.865 39.517 93.2 0.25 0.98 1.02 75%
Trial 2
Control 6 2606 712.16 297 82.69 38.99 88.2 - - - -
Aquaporin 6 956 237.31 236 60.06 28.21 82.9 0.37 0.91 0.94 68%
aNET = Reduction in tick numbers = Total number of ticks from the immunized group / Total number of ticks from the control group.
bEWPF = Reduction in weight of eggs per female = (Total weight of eggs from the immunized group/ Total number of ticks from immunized group) / (Total weight
of eggs from the control group / Total number of ticks from control group).
cH = Reduction in hatchability = % hatch from immunized group / % hatch from control group.
dEff = % Overall efficacy compared to control =100 [1-(NET x EWPF x H)].
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while R. microplus parasitizes a single host with a rela-
tively fast life cycle. Also, IrAQP1 and RmAQP1 could
be members of different aquaporin families as they
have different expression patterns in different tick tis-
sues. RmAQP1 was expressed most highly in the syn-
ganglia of both males and females (Table 2), while
IrAQP1 was not detected in male adult I. ricinus or the
synganglia of adult female I. ricinus [33]. Ball et al.
[34] characterized the RsAQP1 from R. sanguineus and
found highly similar amino acid sequence and a similar
tissue expression pattern as IrAQP1. They described
the tick aquaporins as falling into two families based
on phylogenetic analysis of the existing aquaporinFigure 6 ELISA results from cattle vaccination trials using recombinan
plotted against trial day number for both the cattle group vaccinated with
(dashed line and triangles) and the control group vaccinated with PBS plus
31, 41, 55, 62, 69, and 114 of the test. Three arrows indicate the days of the
is noted by an arrow with asterisk.sequences at the time. Our phylogenetic analysis (Figure 3)
maintains the relationships between the aquaporins of
R. appendiculatus, R. sanguineus, I. ricinus, and D. variabilis
noted by Ball et al. [34] with two families of aquaporins
noted. However, in our phylogenetic analysis the inclusion
of the additional 3 aquaporins from R. microplus discovered
in our studies and our use of a different I. scapularis aqua-
porin appears to break out an additional aquaporin family
that includes RmAQP1. This is consistent with our tissue ex-
pression results, as RmAQP1 is the first reported tick aqua-
porin that has substantial expression in synganglion tissue.
We attempted to determine a classification of the RmAQP1-
3 in conjunction with the human aquaporin classifications
to perhaps learn more about the aquaporins from R.t expressed fragment of RmAQP1. Relative readings from ELISAs are
the recombinant expressed fragment of RmAQP1 in PBS plus adjuvant
adjuvant (solid line and circles). Blood was drawn on days 1, 7, 14, 21,
initial vaccination and the two boosters. The day of larval infestation
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NCBI nr protein database entries for Homo sapiens, all 3 R.
microplus aquaporins had highest sequence similarity to sev-
eral HsAQP7-like transcripts, an aquaglyceroporin (data not
shown). However, there was also significant similarity to
other aquaporin families, including HsAQP3, HsAQP10,
HsAQP9, HsAQP4. Thus, this approach did not shed much
light upon the transport capabilities of the aquaporins
of R. microplus.
Conclusion
We have identified 3 aquaporin-like full length ORFs
from R. microplus transcriptome datasets and a large
part of one of those aquaporins, RmAQP1, was discov-
ered to be an efficacious vaccine antigen in Brazilian
Holstein calves infested with larvae from the Campo
Grande strain of R. microplus. Further work is underway
to evaluate the general effectiveness of this vaccine in
different breeds of cattle and different geographical
locations.
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